CorMedix
CRMD
#7452
Rank
A$0.78 B
Marketcap
A$10.07
Share price
-2.74%
Change (1 day)
-42.65%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2026 (TTM): A$0.27 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.40 Billion. In 2025 the company made an earning of A$0.21 Billion, an increase over its 2024 earnings that were of -A$27.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.27 B29.36%
2025 A$0.21 B-876.29%
2024 -A$27.4 Million-58.3%
2023 -A$65.7 Million53%
2022 -A$42.95 Million2.81%
2021 -A$41.77 Million8.32%
2020 -A$38.57 Million26.53%
2019 -A$30.48 Million-19.89%
2018 -A$38.04 Million-18.72%
2017 -A$46.81 Million34.56%
2016 -A$34.78 Million34.88%
2015 -A$25.79 Million-11.08%
2014 -A$29 Million124.69%
2013 -A$12.91 Million144.91%
2012 -A$5.27 Million-48.41%
2011 -A$10.22 Million-33.29%
2010 -A$15.32 Million78.42%
2009 -A$8.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.33 B 789.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$19.04 M-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$83.79 M-68.06%๐Ÿ‡บ๐Ÿ‡ธ USA